Summary
Tissue samples derived from two neuroepithelial tumours and five meningiomas were obtained at surgery from seven patients and cultured in order to study the effect of dexamethasone (DEX) and testosterone acetate (TA) on cell proliferation.
Glucocorticoid and androgen receptors (GR, AR) were determined both on tissue samples (7 cases) and on five out of the seven cell cultures obtained by tumours.
GR and AR were present respectively in 5 and in 4 out of the tumour specimens assayed and in 4/5 and 2/3 of the tested cell cultures.
DEX activity on cell growth was tested on six cell cultures. Four of them showed a significant growth inhibition at the highest drug concentration. On the contrary, a significant growth stimulation was observed in four out of the five cultures, where GR were present, using low hormone concentrations. Treatment with pharmacological doses of TA caused a significant cytotoxicity in all the tested cultures. Low TA concentrations inhibited cell growth in one out of the two cell cultures which contained AR, but were ineffective in cultures lacking AR.
Our preliminary results suggest a possible role in growth regulation by DEX and TA in intracranial tumours, on the basis of the presence of specific hormone receptors.
Similar content being viewed by others
References
Allegra JC, Lippman ME, Thompson EB, Simon R (1979) Relationship between the progesterone, androgen and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer. Cancer Res 39: 1973–1979
Bischerstaff ER, Small JM, Guest IA (1958) The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psych 21: 89–91
Bonte J (1983) Hormone dependency and hormone responsiveness of endometrial adenocarcinoma to estrogens, progestogens and antiestrogens. In: Campio L, Robustelli Della Cuna R, Taylor RW (eds) Role of medroxyprogesterone in endocrine-related tumors. Raven Press, New York, pp 141–156
Burton KA (1956) A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62: 315–323
Bumma C, Bertetto O, Gentile G (1983) The treatment of ovarian cancer with medroxyprogesterone acetate. In: Campio L, Robustelli Della Cuna G, Taylor RW (eds) Role of medroxyprogesterone in endocrine-related tumors. Raven Press, New York, pp 177–181
Cahill DW, Bashirelahi N, Solomon LW, Dalton T, Saleman M, Ducker TB (1984) Estrogen and progesterone receptors in meningiomas. J Neurosurg 60: 985–993
Courriere P, Tremoulet M, Eche N, Armand JP (1985) Hormonal steroid receptors in intracranial tumors and their relevance in hormone therapy. Eur J Cancer Clin Oncol 21: 711–714
Crabtree GR, Smith RA, Munck A (1978) Glucorticoid receptors and sensitivity of isolated human leukemia and lymphoma cells. Cancer Res 38: 4268–4272
Ekman P, Dahlberg E, Gustafsson JA, Hogberg B, Pousette A, Snochowski M (1980) Present and future clinical value of stereoid receptors assay in human prostatic carcinoma. In: Iacobelli S, King RJB, Lindner HR, Lippman ME (eds) Hormones and Cancer. Raven Press, New York, pp 361–370
Glik RP, Molteni A, Fors EM (1983) Hormone binding in brain tumors. Neurosurg 13: 513–519
Godolphin W, Elwwod JM, Spinelli JS (1981) Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: a study of 583 patients. Int J Cancer 26: 677–683
Grunberg SM, Daniels AM, Muensch H, Daniels JR, Bernstein L, Cortes V, Weiss MH (1987) Correlation of meningioma hormone receptor status with hormone sensitivity in a tumor stem cell assay. J Neurosurg 66: 405–408
Gurner M, Freshney RI, Morgan D, Freshney MG, Thomas DGT, Graham DI (1977) Effects of dexamethasone on in vitro cultures from human astroytomas. Br J Cancer 35: 439–447
Hinton D, Mobbs EG, Sima AA, Hanna W (1983) Steroid receptors in meningiomas. A histochemical and biochemical study. Acta Neuropathol 62: 134–140
Horwitz KB, McGuire WL, Pearson OH, Segaloff A (1977) Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science 189: 726–727
Jay JR, MacLaughlin DT, Riley KR, Martuza RL (1985) Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg 62: 757–762
Knerich R, Scerrati M, Butti G, Sica G, Zibera C, Silvani V, Robustelli della Cuna G, Rossi GF (1987) Steroid hormone receptors and intracranial tumors. In: Chatel M, Darcel F (eds) Brain oncology. Dordrecht, Martunus Nijhoff, pp 159–163
Lippman ME, Halterman RH, Leventhal BG, Perry S, Thompson EB (1973) Glucocorticoid binding proteins in human leukemic lymphoblasts. Nature (New Biol) 242: 157–160
Lippman ME, Yarbro GK, Leventhal BG (1978) Clinical implications of glucocorticoid receptors in human leukemia. Cancer Res 38: 4251
Markwalder TM, Waelti E, Konig MP (1987) Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Surg Neurol 28: 3–9
Martin JD, Hahnel R, McCartney AJ (1982) Prognostic value of estrogen receptors in cancer of the uterine cervix. New Engl J Med 306: 405–409
Matsuota S, Araki Y, Numaguchi K, Ueno S (1978) The effect of dexamethasone on electroencephalogram in patients with brain tumors. J Neurosurg 48: 601–608
McGuire WL, De La Garza MI (1973) Improved sensitivity in the measurement of estrogen receptors in human breast cancer. J Clin Endocrinol Metab 36: 548–552
McGuire WL, Carbone PP, Sears ME, Escher GC (1975) Estrogen receptors in human breast cancer: an overview. In: McGuire WL, Carbone PP, Voelmer EP (eds) Estrogen receptors in human breast cancer. Raven Press, New York, pp 1–7
Natoli C, Sica G, Natoli V, Serra A, Iacobelli S (1983) Two new estrogen supersensitive variants of the MCF-7 human breast cancer cell line. Breast Cancer Res Treat 3: 23–32
Olson JJ, Beck W, Schlechte JA, Low PM (1987) Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice. J Neurosurg 66: 584–587
Poisson M, Pertuiset BF, Hauw JJ, Philippon J, Buge A, Moguilewski M, Philibert D (1983) Steroid hormone receptors in human meningiomas, gliomas and brain metastases. J Neuro-Oncol 1: 179–189
Pollow K, Lubbert H, Boquoi E, Kreuzer G, Pollow B (1975) Characterization and comparison of receptors for 17-beta estradiol and progesterone in human proliferative endometrium and endometrial carcinoma. Endocrinology 96: 319–328
Rausing A, Ybo W, Stenflo J (1970) Intracranial meningioma. A population study of ten years. Acta Neurol Scand 46: 102–110
Schnegg JF, Gomez F, Le Marchand-Berand T, De Tribolet N (1981) Presence of sex steroid hormone receptors in meningioma tissue. Surg Neurol 15: 415–416
Schoenberg BS, Christine BW, Whisnant JP (1975) Nervous system neoplasm and primary malignancies of other sites. The unique association between meningiomas and breast cancer. Neurology 25: 705–712
Schwartz MR, Randolph RL, Cech DA, Rose JE, Panko WB (1984) Steroid hormone binding macromolecules in meningiomas. Failure to meet criteria of specific receptor. Cancer 53: 922–927
Sica G, Natoli V, Marchetti P, Piperno S, Iacobelli S (1984) Tamoxifen induced membrane alteration in human breast cancer cells. J Steroid Biochem 20: 425–428
Stedman KE, Moore GE, Morgan R (1980) Estrogen receptor proteins in diverse human tumors. Arch Surg 115: 244–248
Tilzer LL, Plapp FV, Evans JP, Stone D, Alward K (1982) Steroid receptor proteins in human meningiomas. Cancer 49: 633–636
Yu ZY, Wrange O, Boethius J, Hatam A, Granholm L, Gustafsson JA (1981) A study of glucocorticoid receptors in intracranial tumors. J Neurosurg 55: 757–760
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gibelli, N., Zibera, C., Butti, G. et al. Hormonal modulation of brain tumour growth: a cell culture study. Acta neurochir 101, 129–133 (1989). https://doi.org/10.1007/BF01410528
Issue Date:
DOI: https://doi.org/10.1007/BF01410528